Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats
Author(s) -
Dan Liang,
Zhanrong Li,
Yao Lin,
Jingguo Li,
Zhang,
Xianghua Wu,
Yi Liu,
Miaoli Lin,
Wenru Su,
Yongping Li
Publication year - 2012
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s27860
Subject(s) - celastrol , corneal neovascularization , chemistry , angiogenesis , umbilical vein , cornea , vascular endothelial growth factor , neovascularization , microbiology and biotechnology , biophysics , materials science , biochemistry , medicine , in vitro , apoptosis , biology , cancer research , ophthalmology , vegf receptors
Celastrol, a traditional Chinese medicine, is widely used in anti-inflammation and anti-angiogenesis research. However, the poor water solubility of celastrol restricts its further application. This paper aims to study the effect of celastrol nanoparticles (CNPs) on corneal neovascularization (CNV) and determine the possible mechanism.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom